0|chunk|Efficacy of glucocorticoids for the treatment of macrolide refractory mycoplasma pneumonia in children: meta- analysis of randomized controlled trials
0	59	69 refractory	Phenotype	HP_0031375
0	81	90 pneumonia	Phenotype	HP_0002090

1|chunk|Background: Mycoplasma pneumoniae is one of the most common pathogens causing community acquired pneumonia in children. Although the rate of macrolide-refractory Mycoplasma pneumoniae (MRMP) has increased, systemic glucocorticoids as a treatment option has not been validated yet. The purpose of this study was to assess the efficacy of glucocorticoids add-on in the treatment of MRMP in children through systematic review and meta-analysis. Methods: Data sources A systematic literature search was conducted using ten electronic bibliographic databases including English, Korean, Chinese and Japanese languages, up to March 8, 2018.
1	97	106 pneumonia	Phenotype	HP_0002090

2|chunk|The study was conducted according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses checklist and selected randomized control trials which compared the efficacy of glucocorticoids add-on to macrolide in the treatment of MRMP in children.

3|chunk|Two independent reviewers extracted: primary outcomes as hospital days, fever duration, and change in C-reactive protein (CRP) and main analysis was performed through meta-analysis with random effects model.
3	72	77 fever	Phenotype	HP_0001945

4|chunk|(Continued on next page)

